benzinga.comBiogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impactabout 20 hours ago
cnbc.comStocks making the biggest moves midday: Boeing, Nike, Lockheed Martin, FedEx, Micron Technology and moreabout 1 month ago
businesswire.comNewleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines3 months ago
prnewswire.comAlnylam Pharmaceuticals receives a prestigious "Tell Award" for business investment in Switzerland3 months ago
businesswire.comAlnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference5 months ago
businesswire.comAlnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference5 months ago
businesswire.comKalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors5 months ago
businesswire.comAlnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy5 months ago
benzinga.comBristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks6 months ago
CashuAlnylam Pharmaceuticals Celebrates FDA Approval of Amvuttra, Enhancing Market Confidence and Growthabout 1 month ago
CashuAlnylam Pharmaceuticals' Newleos Secures $93.5M for Innovative Mental Health Solutions3 months ago
CashuAlnylam Pharmaceuticals Honored with 2024 Tell Award for U.S.-Swiss Biotech Innovation3 months ago